News
01 April 2021
EU
Asthma , Allergy

Through ImmUniverse, EFA is involved in research aiming to improve diagnostic and therapeutic options for patients living with immune-mediated inflammatory diseases, including atopic eczema. EFA coordinates a Patient Input Platform (PIP) to ensure the project achieves a patient-centred focus.

On 26-27th January 2021, ImmUniverse held its first annual meeting after the kick-off one year ago. The progress of the project is evolving despite being affected by the COVID-19 pandemic. This has led to limited involvement of the PIP within the research activities during the first year.

Meanwhile, as a member of the Communications Committee of ImmUniverse EFA supported the development of communication materials of the project, ensuring the production of patient-friendly outcomes. This included reviewing the content and structure of the project’s website and promotional video.  

More information on the project can be found here.